5 Results for "

Q-VD

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Q-VD" in MCE Product Catalog:

113
113 Cited Publications
Art. -Nr.: HY-12305
CAS. Nr.: 1135695-98-5
Reinheit:  99.92%
Synonyms: QVD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone
Target:  

Caspase HIV

Forschungsgebiete:  

Infection Cancer

Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
loading...
    loading...
Art. -Nr.: HY-12305A
Synonyms: (R)-QVD-OPH; (R)-Quinoline-Val-Asp-Difluorophenoxymethylketone
Target:  

Apoptosis

Forschungsgebiete:  

Cancer

(R)-Q-VD-OPh ((R)-QVD-OPH) is the less active enantiomer of Q-VD-OPha. Q-VD-OPha is an irreversible pan-caspase inhibitor with potent antiapoptotic properties.
loading...
    loading...
Art. -Nr.: HY-12305G
CAS. Nr.: 1135695-98-5
Q-VD-OPh (GMP) is Q-VD-OPh (HY-12305) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
loading...
    loading...
Art. -Nr.: HY-167707
CAS. Nr.: 402592-44-3
Target:  

Apoptosis

Forschungsgebiete:  

Cancer

Q-VD(OMe)-OPh is a broad-spectrum caspase inhibitor with high activity in inhibiting apoptosis. Q-VD(OMe)-OPh is not toxic to cells at high concentrations, demonstrating its safety. Q-VD(OMe)-OPh exhibits comparable effectiveness to other widely used inhibitors in preventing apoptosis mediated by caspase 9/3, caspase 8/10, and caspase 12 .
loading...
    loading...
Art. -Nr.: HY-184471
CAS. Nr.: 2599098-78-7
Forschungsgebiete:  

Cancer

BCL-XL-IN-5 is an orally active, highly selective BH3-mimetic BCL-XL inhibitor with a cKi of 7.96 pM. BCL-XL-IN-5 triggers caspase-3 activation and robust PARP cleavage to initiate apoptosis in BCL-XL-dependent MOLT-4 T-cell acute lymphoblastic leukemia cells. BCL-XL-IN-5 serves as a potent selective probe for investigating BCL-XL-dependent malignancies, such as acute lymphoblastic leukemia .
loading...
    loading...